Q2 2019 Vanda Pharmaceuticals Inc Earnings Call Transcript
VNDA Stock | USD 4.76 0.06 1.24% |
About 56% of Vanda Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Vanda Pharmaceuticals suggests that many traders are alarmed. Vanda Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Vanda Pharmaceuticals. The current market sentiment, together with Vanda Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Vanda Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Vanda Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Vanda daily returns and investor perception about the current price of Vanda Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Vanda |
Jul 31, 2019 0830PM GMTOperator Good day, ladies and gentlemen, and welcome to Vanda Pharmaceuticals Second Quarter 2019 Earnings Conference Call. Operator
Read at gurufocus.com
Vanda Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Vanda Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Vanda Pharmaceuticals Fundamental Analysis
We analyze Vanda Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vanda Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vanda Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Vanda Pharmaceuticals is currently under evaluation in gross profit category among related companies. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Vanda Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vanda Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Vanda Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Vanda Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Vanda Pharmaceuticals Related Equities
TIL | Instil Bio | 3.24 | ||||
LQDA | Liquidia Technologies | 3.05 | ||||
CNTB | Connect Biopharma | 1.46 | ||||
NUVB | Nuvation Bio | 1.36 | ||||
GPCR | Structure Therapeutics | 1.02 | ||||
RVMD | Revolution Medicines | 0.46 | ||||
CGEM | Cullinan Oncology | 0.41 | ||||
TSVT | 2Seventy Bio | 0.65 | ||||
PCVX | VaxcyteInc | 0.79 | ||||
RLAY | Relay TherapeuticsInc | 1.06 | ||||
BMRN | Biomarin Pharmaceutical | 1.67 | ||||
BPMC | Blueprint Medicines | 1.89 | ||||
CYTK | Cytokinetics | 1.94 | ||||
TECH | Bio Techne | 2.02 | ||||
KZR | Kezar Life | 2.38 | ||||
RCUS | Arcus Biosciences | 2.56 | ||||
LEGN | Legend BiotechCorp | 3.10 | ||||
ANNX | AnnexonInc | 3.19 | ||||
PHAT | Phathom Pharmaceuticals | 3.42 | ||||
REPL | Replimune | 3.50 | ||||
STOK | Stoke Therapeutics | 7.00 |
Check out Vanda Pharmaceuticals Hype Analysis, Vanda Pharmaceuticals Correlation and Vanda Pharmaceuticals Performance. For information on how to trade Vanda Stock refer to our How to Trade Vanda Stock guide.Note that the Vanda Pharmaceuticals information on this page should be used as a complementary analysis to other Vanda Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Vanda Stock analysis
When running Vanda Pharmaceuticals' price analysis, check to measure Vanda Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vanda Pharmaceuticals is operating at the current time. Most of Vanda Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vanda Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vanda Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vanda Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Vanda Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vanda Pharmaceuticals. If investors know Vanda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vanda Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share 0.04 | Revenue Per Share 3.357 | Quarterly Revenue Growth (0.30) | Return On Assets (0.01) |
The market value of Vanda Pharmaceuticals is measured differently than its book value, which is the value of Vanda that is recorded on the company's balance sheet. Investors also form their own opinion of Vanda Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vanda Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vanda Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vanda Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vanda Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vanda Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vanda Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.